The efficacy of the immuknow assay for evaluating the immune status in human immunodeficiency virus and hepatitis C virus-coinfected patients

Transplantation Proceedings

Volumn 46, Issue 3, 2014, Pages 733-735

  Natsuda, K ^a   Soyama, A ^a   Takatsuki, M ^a   Hidaka, M ^a   Kitasato, A ^a   Adachi, T ^a   Kuroki, T ^a   Eguchi, S ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE CELL FUNCTION ASSAY; IMMUNE STATUS; LIVER TRANSPLANTATION; MIXED INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; COMPLICATION; IMMUNOLOGY; METABOLISM;

ADENOSINE TRIPHOSPHATE; HEPATITIS C; HIV INFECTIONS; HUMANS;

EID: 84899495111     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.11.119     Document Type: Conference Paper

References (13)

1. S. Eguchi, A. Soyama, and M. Hidaka et al. Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan Surg Today 41 2011 1325
2. K. Tsukada, Y. Sugawara, and J. Kaneko et al. Living donor liver transplantations in HIV-and hepatitis C virus-coinfected hemophiliacs: experience in a single center Transplantation 15 2011 1261
3. M. Takatsuki, A. Soyama, and S. Eguchi Liver transplantation for HIV/hepatitis C virus co-infected patients Hepatol Res 44 2014 17
4. H. Kovari, B. Ledergerber, and U. Peter et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study Clin Infect Dis 49 2009 626
5. E. Vispo, A. Moreno, and I. Maida et al. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings AIDS 24 2010 1171
6. N. Merchante, J.A. Girón-González, and M. González-Serrano et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease AIDS 20 2006 49
7. M.V. Ragni, B. Eghtesad, and K.W. Schlesinger et al. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease Liver Transpl 11 2005 1425
8. R. Kowalski, D. Post, and M.C. Schneider et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management Clin Transplant 17 2003 77
9. R.J. Kowalski, D.R. Post, and R.B. Mannon et al. Assessing relative risks of infection and rejection: ameta-analysis using an immune function assay Transplantation 82 2006 663
10. R. Cabrera, M. Ararat, and C. Soldevila-Pico et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients Liver Transpl 15 2009 216
11. F. Xue, J. Zhang, and L. Han et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection Transplantation 89 2010 620
12. J.Y. Dong, H. Yin, and R.D. Li et al. The relationship between adenosine triphosphate within CD4(+) T lymphocytes and acute rejection after liver transplantation Clin Transplant 25 2011 E292
13. E. Rodrigo, M. López-Hoyos, and M. Corral et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis Liver Transpl 18 2012 1245